MENU
+Compare
CTKB
Stock ticker: NASDAQ
AS OF
Nov 21, 02:28 PM (EDT)
Price
$5.87
Change
+$0.66 (+12.67%)
Capitalization
666.18M

CTKB Cytek Biosciences Forecast, Technical & Fundamental Analysis

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches... Show more

CTKB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for CTKB with price predictions
Nov 20, 2025

CTKB saw its Stochastic Oscillator recovers from the overbought zone

The Stochastic Oscillator for CTKB moved out of overbought territory on November 19, 2025. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 45 similar instances where the indicator exited the overbought zone. In of the 45 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for CTKB moved out of overbought territory on November 19, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 17 similar instances where the indicator moved out of overbought territory. In of the 17 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CTKB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CTKB broke above its upper Bollinger Band on November 14, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 06, 2025. You may want to consider a long position or call options on CTKB as a result. In of 64 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CTKB just turned positive on November 06, 2025. Looking at past instances where CTKB's MACD turned positive, the stock continued to rise in of 37 cases over the following month. The odds of a continued upward trend are .

CTKB moved above its 50-day moving average on November 05, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for CTKB crossed bullishly above the 50-day moving average on October 16, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

The 50-day moving average for CTKB moved above the 200-day moving average on November 06, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CTKB advanced for three days, in of 242 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 116 cases where CTKB Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CTKB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.760) is normal, around the industry mean (62.840). P/E Ratio (0.000) is within average values for comparable stocks, (35.504). CTKB's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.646). CTKB has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (3.388) is also within normal values, averaging (84.272).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CTKB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
CTKB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

CTKB is expected to report earnings to fall 60.00% to -1 cents per share on March 04

Cytek Biosciences CTKB Stock Earnings Reports
Q4'25
Est.
$-0.02
Q3'25
Missed
by $0.01
Q2'25
Est.
$-0.04
Q1'25
Missed
by $0.07
Q4'24
Beat
by $0.01
The last earnings report on November 05 showed earnings per share of -3 cents, missing the estimate of -2 cents. With 849.51K shares outstanding, the current market capitalization sits at 666.18M.
A.I. Advisor
published General Information

General Information

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
N/A
Address
47215 Lakeview Boulevard
Phone
+1 877 922-9835
Employees
676
Web
https://www.cytekbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MMKBX26.33N/A
N/A
Morgan Stanley Inst Emerging Mkts A
TRXCX12.30N/A
N/A
Catalyst/MAP Global Balanced C
KTRZX9.55N/A
N/A
DWS Global Income Builder R6
RTSAX38.52-0.55
-1.41%
Russell Inv Tax-Managed US Mid&Sm Cap A
MRGBX44.28-0.68
-1.51%
MFS Core Equity B

CTKB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CTKB has been loosely correlated with BRKR. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if CTKB jumps, then BRKR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTKB
1D Price
Change %
CTKB100%
-0.95%
BRKR - CTKB
47%
Loosely correlated
+1.01%
CRL - CTKB
44%
Loosely correlated
+0.27%
RVTY - CTKB
42%
Loosely correlated
+1.92%
LAB - CTKB
41%
Loosely correlated
+0.39%
A - CTKB
39%
Loosely correlated
+0.46%
More

Groups containing CTKB

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTKB
1D Price
Change %
CTKB100%
-0.95%
Medical/Nursing Services
industry (216 stocks)
32%
Poorly correlated
-1.75%
Health Services
industry (423 stocks)
4%
Poorly correlated
-1.14%